Global Battery Materials Corp. ("GBM" or the "Company"), a vertically integrated critical minerals and technology company ...

By renewing its CAC designation, Traverse Tall Ship Company continues to support Traverse City's Certified Autism ...

PTC Inc. stock is a Buy as Creo & Windchill drive R&D lock-in, 27% RPO growth, and 95% recurring revenue, plus $365M buybacks. Click here to read more on PTC.

Net proceeds anticipated to extend cash runway into first quarter of 2027; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend into second half of 2027 to ...

ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum ...

The PV5 is more than your typical van. It’s an all-electric people mover that uses Hyundai’s flexible EV platform and latest software for an all-in-one total mobility solution. After launching the ...

Windows 11/10 creates a number of system files and folders to support the running of the operating system. The ProgramData folder is one of those important system folders. It contains all the data for ...

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announced the signing of a Memorandum of Understanding (MoU) with Taylor’s University and IME Technology to implement the SOLIDWORKS SkillForce ...

PONTE VEDRA, Fla., April 30, 2026 (GLOBE NEWSWIRE)-- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing innovative treatments for life-threatening immune and thrombotic ...

Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to standard anticoagulant therapy PONTE VEDRA, Fla., April 30, 2026 (GLOBE NEWSWIRE)-- Cadrenal ...

PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and ...

Ruminant BioTech—a New Zealand-based startup with “slow-release” livestock methane reduction tech for pasture-based cattle—has launched a CAD$7.6 million ($5.6 million) research program to validate ...